A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Glioblastoma|Head and Neck Squamous Cell Carcinoma|Malignant Mesothelioma|Non-small Cell Lung Cancers|Sarcoma|Endometrial Cancer
Interventions: DRUG: PRT3645
Sponsor: Prelude Therapeutics